Suggestions

Du même auteur

Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)

Archive ouverte | Bayle, A. | CCSD

International audience

Liquid versus tissue biopsy for detecting actionable alterations according to ESCAT in patients with advanced cancer: A study from the French National Center for Precision Medicine (PRISM)

Archive ouverte | Bayle, A. | CCSD

International audience

Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients

Archive ouverte | Chen, J. | CCSD

International audience. Background: The development of targeted agents, such as osimertinib for EGFR-mutated non-small-cell lung cancer (NSCLC), has drastically improved patient outcome, but tumor resistance eventua...

Chargement des enrichissements...